SCHEMBL16168604

SCHEMBL16168604

C=C(O)C(C)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.45
ADRA2C P18825 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
ADRA2A P08913 1/20 0.44
HIF1A Q16665 1/20 0.44
HPGD P15428 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CHRM2 P08172 1/20 0.41
ADRA1A P35348 1/20 0.41
RGS12 O14924 1/20 0.41
GLA P06280 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13176481 1.00 PTGS2 (0.45) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL13177031 1.00 PTGS2 (0.45) PTGS2ADRA2CKDM4ELMNAADRA2A
Ammonia Solution, Strong SCHEMBL11508344 0.82 PTGS2 (0.43) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL4813777 0.82 PTGS2 (0.43) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL2163297 0.82 HPGD (0.47) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL16594346 0.80 PTGS2 (0.42) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL10628842 0.80 PTGS2 (0.47) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL9797484 0.80 PTGS2 (0.42) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL1814078 0.78 PTGS2 (0.41) PTGS2ADRA2CKDM4ELMNAADRA2A
SCHEMBL9717408 0.78 SMN1; SMN2 (0.47) PTGS2ADRA2CKDM4ELMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2531490-B1 CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2014-10-15 EP disclosed